...Abgenix Inc. up $3.00 at $17.70 Investors interpreted the good news for Tarceva as boosting prospects for this biotech's own cancer drug. Abatix Corp. down $1.55 at $7.23 A shareholder lawsuit was announced late Friday against the company...